Sort
85,873 grants matching “alzheimers”
Medicinal Chemistry and Chemical Biology Core
$1,749,509Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2019 · AG
The role of peripheral versus brain myeloid immunity in the cognitive decline of aging and Alzheimer's disease
$1,749,426Katrin I Andreasson · Stanford University · RF1 · FY2022 · AG
Arizona Alzheimer's Disease Core Center
$1,749,146Eric M Reiman · Arizona State University-Tempe Campus · P30 · FY2018 · AG
Consequences of Locus Coeruleus Activation in a Rat Model of Alzheimer's Disease
$1,747,125David Weinshenker · Emory University · RF1 · FY2014 · AG
Role of the steroid hormone ADIOL in learning and memory, aging, and neurodegeneration
$1,747,068Kaveh Ashrafi · University Of California, San Francisco · RF1 · FY2021 · AG
Wake Forest Alzheimer's Disease Core Center
$1,746,797Suzanne Craft · Wake Forest University Health Sciences · P30 · FY2017 · AG
Wake Forest Alzheimer's Disease Core Center
$1,746,765Suzanne Craft · Wake Forest University Health Sciences · P30 · FY2016 · AG
Bio-Organic Biomedical Mass Spectrometry Resource
$1,746,341Alma L Burlingame · University Of California, San Francisco · P41 · FY2014 · GM
Women's Health Initiative Sleep Hypoxia Effects on Resilience (WHISPER)
$1,745,436Laura D. Baker · Wake Forest University Health Sciences · R01 · FY2018 · HL
Clonal and imaging analyses of in vivo hematopoiesis, immune cell ontogeny and adoptive cell therapies
$1,745,118Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
ADMINISTRATIVE CORE
$1,744,623Paul S. Aisen · University Of California, San Diego · U19 · FY2015 · AG
Alzheimer's Disease Concept- OLFACTION AS AN EARLY BIOMARKER OF Alzheimer's Disease
$1,744,498Vilhelm A Bohr · National Institute On Aging · ZIA · FY2021 · AG
The POINTER Neurovascular Ancillary Study
$1,744,051Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2024 · AG
The role of 24-hour activity cycles in preserving cognitive function and preventing Alzheimer's disease and related dementias
$1,743,923Keith M Diaz · Columbia University Health Sciences · R01 · FY2025 · AG
Alzheimer's Disease Research Center
$1,743,823Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2011 · AG
Sex Differences in Epigenetic Parent-of-X Origin and Alzheimer's Disease
$1,743,758Dena Bou Dubal · University Of California, San Francisco · RF1 · FY2022 · AG
Mayo Alzheimer's Disease Research Center
$1,743,645Ronald C Petersen · Mayo Clinic Rochester · P50 · FY2013 · AG
Anatomic, Physiologic, and Cognitive Pathology of AD
$1,743,608Leyla De Toledo-Morrell · Rush University Medical Center · P01 · FY2006 · AG
Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimerâs disease risk in older Blacks/African-Americans
$1,743,570Omonigho A Michael Bubu · New York University School Of Medicine · R01 · FY2023 · AG
Down Syndrome: Toward Optimal Trajectories and Health Equity using Medicaid Analytic eXtract (DS -TO-THE-MAX)
$1,743,481Eric S Rubenstein · Boston University Medical Campus · R01 · FY2021 · AG
ISCHEMIC PRECONDITIONING: MECHANISMS OF NEUROPROTECTION
$1,742,667Miguel A Perez-Pinzon · University Of Miami School Of Medicine · RF1 · FY2022 · NS
MICHIGAN ALZHEIMERS DISEASE RESEARCH CENTER
$1,742,196University Of Michigan At Ann Arbor · P50 · FY2002 · AG
Alzheimer's Disease Core Center
$1,741,603John Q. Trojanowski · University Of Pennsylvania · P30 · FY2017 · AG
China Health and Retirement Longitudinal study
$1,739,936Yafeng Wang · Peking University · R01 · FY2024 · AG
ADCC Genomic Medicine Approach to MCI and Dementia
$1,739,671Kathleen Anne Welsh-Bohmer · Duke University · P30 · FY2007 · AG